Clinical study of the association between n-3 PUFA and statin effects on inflammation and lipids.
Phase of Trial: Phase III
Latest Information Update: 17 May 2011
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; HMG-CoA reductase inhibitors; Omega 3 fatty acids
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 17 May 2011 New trial record